Tamil Nadu Saves Funds On Drugs For Hospitals
Tamil Nadu (a state of India) Health Minister Arcot Veerasamy has said the government has saved some $11.8 million in the purchase of drugs and medicines for the public-sector hospitals. Mr Veerasamy claimed the previous government of the Indian state had bought medicines at "exorbitant rates" and that former Health Secretary Inbasagaran had procured drugs "far in excess of demand." Drugs worth considerable sums had been found to be unusable and had been dumped. The Minister said the procedure has now been streamlined and there is now no complaint of shortages of medicines from any hospitals anywhere in the state.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze